Astrazeneca Pharma India reports standalone net profit of Rs 2.72 crore in the June 2015 quarter

Sales decline 4.41% to Rs 120.03 crore

Net profit of Astrazeneca Pharma India reported to Rs 2.72 crore in the quarter ended June 2015 as against net loss of Rs 17.60 crore during the previous quarter ended June 2014. Sales declined 4.41% to Rs 120.03 crore in the quarter ended June 2015 as against Rs 125.57 crore during the previous quarter ended June 2014. ParticularsQuarter EndedJun. 2015Jun. 2014% Var.Sales120.03125.57 -4 OPM %4.41-12.71 -PBDT7.00-14.17 LP PBT2.72-17.60 LP NP2.72-17.60 LP

Powered by Capital Market - Live News